Chemistry Reference
In-Depth Information
[12] Lombardino JG; Lowe JA. A guide to drug discovery:The role of the medicinal chemist in
drug discovery - then and now. Nat. Rev. Drug Discov. 2004; 3: 853-862.
[13] Paul SM, Mytelka DS, Dunwiddie CT,Persinger CC, Munos BH, Lindborg SR, Schacht AL.
How to improve R&D productivity: the pharmaceutical industry's grand challenge. Nat. Rev.
Drug Discov. 2010; 9: 203-214.
[14] Jahnke W, Widmer H. Protein NMR in biomedical research. CMLS, Cell. Mol. Life Sci.
2004;61: 580-599.
[15] Brian J, Stockman J, Dalvit C. NMR screening techniques in drug discovery and drug design
.
Prog.Nucl.Mag. Res. Sp. 2002; 41: 187-231.
[16] Krajewski M, Rothweiler U, D'Silva L, Majumdar S, Klein C, HolakTA. An NMR-Based
Antagonist Induced Dissociation Assay for Targeting the Ligand−Protein and Protein−Protein
Interactions in Competition Binding Experiments. J. Med. Chem., 2007; 50: 4382-4387.
[17] Patrick GL, Spencer J. An Introduction to Medicinal Chemistry.Oxford University Press; 2009.
[18]. Clarkson J, Campbell ID. Studies of protein-ligand interactions by NMR. Biochem. Soc. Trans.
2003; 31: 1006-1009
[19] Lepre CA, Moore JM, Peng JW. Theory and Applications of NMR-Based Screening in
Pharmaceutical Research. Chem. Rev. 2004; 104: 3641−3675
[20] Riek R, Pervushin K, Wüthrich K. TROSY and CRINEPT: NMR with large molecular and
supramolecular structures in solution.Trends Biochem.Sci. 2000; 25: 462-468.
[21] Hajduk PJ, Augeri DJ, Mack J, Mendoza R, Yang J, Betz SF, Fesik SW. NMR-Based
screening of proteins containing
13
C-labeled methyl groups. J. Am. Chem. Soc. 2000; 122:
7898 - 7904.
[22]
Ladbury, J.E., Hensmann, M., Panayotou, G. and Campbell, I.D.
Alternative Modes of
TyrosylPhosphopeptide Binding to a Src Family SH2 Domain:
Implications for Regulation of
Tyrosine Kinase Activity
.
Biochemistry 1996; 35: 11062-11069
[23] Hajduk PJ, Sheppard G, Nettesheim DG, Olejiniczak ET, Shukar SB, Meadows RP, Steinman
DH, Carrera GM, Marcotte PA, Severin J, Walter K, Smith H, Gubbins E, Simmer R,
Holzman TF, Morgan DW, Davidsen SK, Summers JB, Fesik SW, Discovery of Potent
Nonpeptide Inhibitors of Stromelysin Using SAR by NMR. J. Am. Chem. Soc. 1997; 119:
5818 - 5827.
[24] Shapiro MJ, GounaridesJS. NMR methods utilized in combinatorial chemistry
research.Prog.Nucl.Mag. Res. Sp. 1999; 35: 153-200.
[25] Peng JW, Moore J, Abdul-Manan N. NMR experiments for lead generation in drug
discovery.Prog.Nucl.Mag. Res. Sp. 2004; 44: 225 - 256.
[26] Ludwig C, GuentherUL. Ligand based NMR methods for drug Discovery. Front. Biosci.2009;
14: 4565-4574.
[27] Brand T, Cabrita EJ, Berger S. Intermolecular interaction as investigated by NOE and diffusion
studies. Prog.Nucl.Mag. Res. Sp. 2005; 46: 159-196.
[28] CraikDJ, WilceJ. Protein NMR Techniques. Springer-Verlag New York, LLC 1997; 60:195-
232.
[29] Chen A, ShapiroMJ. NOE Pumping: A Novel NMR Technique for Identification of
Compounds with Binding Affinity to Macromolecules. J. Am. Chem. Soc. 1998; 120: 10258-
10259.
